<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04912440</url>
  </required_header>
  <id_info>
    <org_study_id>EVK-PSE-ERCP RETRO</org_study_id>
    <nct_id>NCT04912440</nct_id>
  </id_info>
  <brief_title>Motorized Spiral Enteroscopy-assisted ERCP in Surgically Altered Anatomy</brief_title>
  <official_title>Motorized Spiral Enteroscopy-assisted ERCP in Surgically Altered Anatomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Evangelisches Krankenhaus D端sseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Evangelisches Krankenhaus D端sseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with surgically altered anatomy receiving Motorized Spiral Eneroscopy (MSE)-assisted&#xD;
      ERCP at a single endoscopic reference center for various indications are planned to be&#xD;
      retrospectively enrolled&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All consecutive patients with altered upper gastrointestinal anatomy after Billroth-II- or&#xD;
      Roux-en-Y reconstructive surgery and indication for ERCP with biliary and/or pancreatic&#xD;
      indication, who underwent routine Enteroscopy-assisted ERCP using MSE, at the study center&#xD;
      during the study period, will be enrolled in the analysis.&#xD;
&#xD;
      Primary endpoint of the study will be efficacy and safety of MSE-assisted ERCP.&#xD;
&#xD;
      Retrospective epidemiologic Study (not interventional) was approved by local IRB and ethical&#xD;
      committee of the North-Rhine Chamber of Physicians (D端sseldorf, Germany), Reference Number:&#xD;
      177/2021.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2021</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Success rate of MSE-ERCP</measure>
    <time_frame>intraprocedural</time_frame>
    <description>rate of subjects with successfull MSE-assisted ERCP</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse event rate of MSE-ERCP</measure>
    <time_frame>3 days</time_frame>
    <description>rate of adverse events during and early after MSE-ERCP</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Success rate of enteroscopy</measure>
    <time_frame>intraprocedural</time_frame>
    <description>rate of subjects with successful enteroscopic access to the papilla</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural duration</measure>
    <time_frame>intraprocedural</time_frame>
    <description>overall time for MSE-ERCP (scope in to scope out)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Ercp in Altered Anatomy</condition>
  <arm_group>
    <arm_group_label>MSE-ERCP</arm_group_label>
    <description>Group of patients, that received motorized spiral enteroscopy assisted ERCP in altered anatomy at the single study center</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MSE-ERCP</intervention_name>
    <description>No interventional study, MSE-ERCP performed within routine treatment, (approved indication of device)</description>
    <arm_group_label>MSE-ERCP</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with surgically altered upper gastrointestinal anatomy and indication for&#xD;
        endoscopic retrograde cholangio-pancreatography&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  altered upper gastrointestinal anatomy after Billroth-II- or Roux-en-Y reconstructive&#xD;
             surgery&#xD;
&#xD;
          -  indication for ERCP with biliary and/or pancreatic indication&#xD;
&#xD;
          -  Enteroscopy-assisted ERCP using MSE, at the study center during the study period&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - due to the retrospective design of the study, no exclusion criteria are defined&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Torsten Beyna, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Evangelisches Krankenhaus D端sseldorf, Department of Gastroenterology and Therapeutic Endoscopy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Torsten Beyna, MD PhD</last_name>
    <phone>00492119191605</phone>
    <email>torsten.beyna@evk-duesseldorf.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Markus Schneider, MD</last_name>
    <phone>00492119191605</phone>
    <email>markus.schneider@evk-duesseldorf.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus</name>
      <address>
        <city>Dusseldorf</city>
        <zip>40217</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Torsten Beyna, MD</last_name>
      <phone>00492119191605</phone>
      <email>Torsten.Beyna@evk-duesseldorf.de</email>
    </contact>
    <investigator>
      <last_name>Horst Neuhaus, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Markus Schneider, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 28, 2021</study_first_submitted>
  <study_first_submitted_qc>May 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 3, 2021</study_first_posted>
  <last_update_submitted>June 18, 2021</last_update_submitted>
  <last_update_submitted_qc>June 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>endoscopy</keyword>
  <keyword>enteroscopy</keyword>
  <keyword>ercp in altered anatomy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No exchange of individual data is planned</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

